Medial EarlySign Company
Medial EarlySign is a company that uses an AI algorithmic platform called AlgoMarkers to discover clinical insights that indicate the likelihood of disease from basic medical information. They collaborate with healthcare organizations to build predictive engines using millions of patient years-worth of data and clinical rigor. The company develops clinical decision support and population health solutions that can help predict clinical outcomes related to various diseases. These tools are designed to empower healthcare organizations with proactive, predictive, and personalized care management capabilities.
Founded Date:
2009-01-01
Technology:
Big Data
Investor Type:
N/A
Funding Status:
Early Stage Venture
Total Funding:
50000000.0
Employee Number:
11-50
Headquarters:
Hod Hasharon, HaMerkaz, Israel
Last Funding Date:
2018-03-06
Investors Number:
5.0
Last Funding Type:
Series B
Estimated Revenue:
$1M to $10M
Investment Stage:
N/A
Number Of Exists:
N/A
Industry:
Early Drug Development